ASHG 2026 · Tools, software & services

Chiesi Global Rare Diseases at ASHG 2026

Boston, Massachusetts

Chiesi Global Rare Diseases at ASHG 2026 in Montréal: Booth 1424.

1424
exhibit booth

Explore everyone at ASHG 2026 →

OrganizationASHG 2026 Attendance
Chiesi Global Rare Diseases
Boston, Massachusetts
chiesirarediseases.com|LinkedIn
Private company
A business unit established to deliver innovative therapies and solutions for people living with rare diseases.
Completed its acquisition of KalVista Pharmaceuticals, adding a rare-disease drug developer and expanding its combined R&D pipeline.
›
Completed its acquisition of KalVista Pharmaceuticals, adding a rare-disease drug developer and expanding its combined R&D pipeline.
2026-06 · source
Won EU approval to use its lomitapide capsules in children as young as 5, expanding the drug's patient population.
2026-06 · source
Entered an exclusive license agreement with Aliada Therapeutics, a wholly owned AbbVie subsidiary, adding a new pipeline program.
2025-11 · source
Source: company newsroom
Currently hiring: 29 open roles
›
Source: careers page
Booth
Exhibiting at Booth 1424
Wed, Oct 219:45am–4:30pmThu, Oct 229:45am–1:30pmFri, Oct 239:45am–4:30pm

Explore the full ASHG 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Montréal. Leave your work email and we’ll be in touch.

Privacy

Meeting Chiesi Global Rare Diseases in Montréal?

Get in-depth attendee and institution profiles and research, to plan your meetings in Montréal. Leave your work email and we’ll be in touch.

Privacy

Not affiliated with or endorsed by the American Society of Human Genetics. Submit a correction